Answer
Breastfeeding can continue during zuclopenthixol dihydrochloride treatment if considered clinically important, with infant observation recommended, particularly during the first four weeks after birth; low breast-milk concentrations are unlikely to affect the infant at therapeutic doses.
Sources for this answer
- Clopixol Tablets 2, 10 and 25mgLundbeck Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 20Document updated
Sources checked